Skip to content

IMDX IMDX Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%
P/S95.1×+72.5×

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's payments of stock issuance costs?
IMDX (IMDX) reported payments of stock issuance costs of $1.18M in Q1 2026.
How has IMDX's payments of stock issuance costs changed year-over-year?
IMDX's payments of stock issuance costs increased by 142.9% year-over-year, from $487K to $1.18M.
What is the long-term trend for IMDX's payments of stock issuance costs?
Over 2 years (2022 to 2024), IMDX's payments of stock issuance costs has grown at a 87.9% compound annual growth rate (CAGR), from $389K to $1.37M.
What does payments of stock issuance costs mean?
Includes direct costs such as legal, accounting, and underwriting fees incurred to raise capital through the issuance of equity securities. Monitoring these costs helps evaluate the efficiency of the company's capital-raising activities.